Skip to main content
. Author manuscript; available in PMC: 2009 Aug 8.
Published in final edited form as: Cancer Lett. 2008 Apr 18;266(2):216–226. doi: 10.1016/j.canlet.2008.02.060

Table 2.

Reduction in the gene expression in perifosine treated PC-3 and LNCaP cells with down-regulated GSK-3β or CREB proteins

Gene GSKi (perifosine) CREBi (perifosine)
% reduction % reduction
PC-3 LNCaP PC-3 LNCaP
AZGP 70 ± 6 60 ± 1
CEACAM5 50 ± 5 44 ± 1
COX-2 65 ± 2
GDF15 79 ± 2 51 ± 10 60 ± 8
ITGB4 58 ± 3
KRT15 62 ± 2
KRT19 52 ± 3
KRT4 73 ± 5 82 ± 2 84 ± 2
KRT6irs4 80 ± 5 75 ± 1 70 ± 2
MIG6 70 ± 1
NDRG1 51 ± 7
S100P 84 ± 1 57 ± 9 48 ± 3 60 ± 5
TNFAIP2 54 ± 2